Establishment of a human induced pluripotent stem cell line (CSUASOi010-A) by reprogramming peripheral blood mononuclear cells of a type 2 diabetic mellitus patient
Summary
Type 2 diabetes mellitus (T2DM) is a major caused by insulin resistance with a relative deficiency in insulin secretion. Statistically, T2DM accounts for 90% of diabetes cases worldwide. We report the patient-specific human induced pluripotent stem cell line (iPSC) CSUASOi010-A by using Peripheral blood mononuclear cells (PBMCs) of a 62-year-old female from Type 2 diabetes mellitus (T2DM). Patient blood-derived cells were reprogrammed using the Sendai virus. Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
| Authors | Ding C, Tan F, Zhou Y, Duan C, Gu J, Cui Z, Chen Z, Tang S, Chen J |
|---|---|
| Journal | Stem cell research |
| Publication Date | 2022 Aug;63:102851 |
| PubMed | 35841806 |
| DOI | 10.1016/j.scr.2022.102851 |